FFCP PHASE1:Hg19::chr4:153587489..153587501,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport= | |||
|DPIdataset=robust | |||
|EntrezGene= | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |||
|HGNC= | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=-18bp_to_ENST00000515789,uc003imx.1_5end | |||
|coexpression_cluster_id=C1568 | |||
|description=CAGE_peak_1_at_ENST00000515789_5end,CAGE_peak_1_at_uc003imx.1_5end | |||
|id=chr4:153587489..153587501,+ | |||
|ontology_enrichment_celltype=CL:0000236!1.18e-65!14;CL:0000945!4.82e-64!24;CL:0000826!4.82e-64!24;CL:0000542!1.98e-30!53;CL:0000051!1.98e-30!53;CL:0000838!1.59e-27!52;CL:0000785!3.96e-12!2;CL:0000955!3.96e-12!2;CL:0000818!3.96e-12!2;CL:0000954!3.96e-12!2;CL:0000816!3.96e-12!2;CL:0002087!3.21e-11!119;CL:0002031!2.78e-09!124;CL:0000738!5.65e-09!140;CL:0000817!2.28e-08!3;CL:0000819!3.73e-07!1;CL:0002032!4.68e-07!165;CL:0000837!4.68e-07!165 | |||
|ontology_enrichment_celltype_v019=CL:0000236;1.61e-93;13!CL:0000945;1.17e-75;24!CL:0000542;1.23e-32;53!CL:0000785;8.19e-17;1!CL:0000819;8.19e-17;1!CL:0002087;1.51e-08;104 | |||
|ontology_enrichment_celltype_v019_2=CL:0000236,5.50e-87,14;CL:0000945,9.50e-76,24;CL:0000826,9.50e-76,24;CL:0000542,2.19e-40,53;CL:0000051,2.19e-40,53;CL:0000838,1.43e-34,52;CL:0002087,6.05e-18,115;CL:0000819,8.86e-17,1;CL:0000738,4.94e-15,136;CL:0002031,2.49e-14,120;CL:0002032,1.52e-12,161;CL:0000837,1.52e-12,161;CL:0000037,5.62e-12,168;CL:0000988,2.59e-11,177;CL:0000785,4.70e-09,2;CL:0000955,4.70e-09,2;CL:0000818,4.70e-09,2;CL:0000954,4.70e-09,2;CL:0000816,4.70e-09,2 | |||
|ontology_enrichment_development_v019=CL:0000051;1.23e-32;53!CL:0000954;4.52e-09;2 | |||
|ontology_enrichment_disease=DOID:0060058!7.48e-14!10;DOID:0060073!3.73e-07!1;DOID:8675!3.73e-07!1;DOID:12603!4.97e-07!1 | |||
|ontology_enrichment_disease_v019=DOID:0060073;8.19e-17;1!DOID:8675;8.19e-17;1!DOID:12603;1.93e-16;1!DOID:0060058;1.31e-14;10 | |||
|ontology_enrichment_disease_v019_2=DOID:0060073,8.86e-17,1;DOID:8675,8.86e-17,1;DOID:12603,1.93e-16,1;DOID:0060058,1.41e-14,10 | |||
|ontology_enrichment_uberon=UBERON:0007023!5.29e-11!115;UBERON:0002372!7.39e-07!1;UBERON:0001961!7.39e-07!1;UBERON:0001744!7.39e-07!1;UBERON:0001735!7.39e-07!1;UBERON:0001154!8.75e-07!1;UBERON:0001153!8.75e-07!1 | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.24654881682875,0.426507697462265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.75996244461323,1.09227722252426,0.889509253863555,0.853460445133014,1.60158394814405,2.87376219977242,0.661044872784862,1.90810750907073,2.84606484554724,3.52342313622563,1.91136614062614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.569647187174163,0.476463550915578,0.411362273086194,0,0,0,0,0,0,1.67222857613147,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.552567831062295,0,0,0,0,0,0,0,0.197286811273867,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.265372693510018,0,0,0,0,0,0,0,2.37191225980366,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213452994739353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.223171457441873,0,0,0,0,0,0,0,0.0846733320657845,0,0,0,0,0,0,0,0,0,0.0788057072991982,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106787412567695,0,0.414239055347196,0,0,3.65377795142688,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.468334905806882,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.345701962667338,0,0,0,0,0,0,0,0,0,0,0,0.0714765441766563,0,0,0,0,0,0,0,0.860454717640555,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.03382309777839,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0636471582781649,0,0.217716747896961,0,0.673520530145875,0.0717222053926763,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p1@ENST00000515789,p1@uc003imx.1 | |||
}} |
Revision as of 03:29, 22 January 2014
Short description: | p1@ENST00000515789, p1@uc003imx.1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_1_at_ENST00000515789_5end, CAGE_peak_1_at_uc003imx.1_5end |
Coexpression cluster: | C1568_lymphoma_CD19_vein_tonsil_Burkitt_non_diffuse |
Association with transcript: | -18bp_to_ENST00000515789, uc003imx.1_5end |
EntrezGene: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B cell | 5.50e-87 | 14 |
lymphocyte of B lineage | 9.50e-76 | 24 |
pro-B cell | 9.50e-76 | 24 |
lymphocyte | 2.19e-40 | 53 |
common lymphoid progenitor | 2.19e-40 | 53 |
lymphoid lineage restricted progenitor cell | 1.43e-34 | 52 |
nongranular leukocyte | 6.05e-18 | 115 |
B-1 B cell | 8.86e-17 | 1 |
leukocyte | 4.94e-15 | 136 |
hematopoietic lineage restricted progenitor cell | 2.49e-14 | 120 |
hematopoietic oligopotent progenitor cell | 1.52e-12 | 161 |
hematopoietic multipotent progenitor cell | 1.52e-12 | 161 |
hematopoietic stem cell | 5.62e-12 | 168 |
hematopoietic cell | 2.59e-11 | 177 |
mature B cell | 4.70e-09 | 2 |
pre-B-II cell | 4.70e-09 | 2 |
transitional stage B cell | 4.70e-09 | 2 |
small pre-B-II cell | 4.70e-09 | 2 |
immature B cell | 4.70e-09 | 2 |
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 8.86e-17 | 1 |
lymphosarcoma | 8.86e-17 | 1 |
acute leukemia | 1.93e-16 | 1 |
lymphoma | 1.41e-14 | 10 |